Share on LinkedInShare on LinkedIn

ARTICLE · 09 DECEMBER 2020

CDC Advisory Committee Issues Recommendations For Initial COVID-19 Vaccine Prioritization

Duane Morris LLP
Duane Morris LLP
Contributor
Explore more from Duane Morris LLP

The afternoon of December 1, 2020, marked an important milestone in the fight against the coronavirus pandemic. The Centers for Disease Control and Prevention ...

United StatesCoronavirus (COVID-19)

The afternoon of December 1, 2020, marked an important milestone in the fight against the coronavirus pandemic. The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) voted 13-1 to approve recommendations to prioritize distribution of the initial doses of COVID-19 vaccines. ACIP took an unusual step, issuing the recommendations before the FDA issues emergency use approval (EUA) of any COVID-19 vaccines so that the recommendations could assist states in developing their own vaccine distribution plans.

The ACIP recommendations are the culmination of months of work by national experts who carefully studied and considered the impacts of the pandemic as well as the pros and cons of various options for prioritizing how initial doses of vaccines should be distributed. With emergency use authorizations expected from the FDA for the first two COVID-19 vaccines—novel mRNA vaccines developed by Pfizer-BioNTech SE and Moderna—within

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

See more popular content from